Moolec Science Completes 15-for-1 Reverse Stock Split to Maintain Nasdaq Listing
Summary
Moolec Science SA has completed a 15-for-1 reverse stock split, significantly reducing outstanding shares to boost its stock price and maintain Nasdaq listing compliance.
Key Events
-
Share Count Reduction
The number of issued and outstanding shares was reduced from 10,891,761 to 726,118 as a result of the consolidation.
-
Nasdaq Compliance
This action is intended to help the company regain compliance with Nasdaq's minimum bid price requirements, as indicated in the forward-looking statements.
-
New CUSIP Number
The company's ordinary shares will trade under the existing symbol "MLEC" but with a new CUSIP number G6223S 125. Warrants (MLECW) retain their CUSIP.
Analysis
Moolec Science SA has completed a 15-for-1 reverse stock split, effective January 5, 2026. This action, which reduced the number of outstanding shares from approximately 10.9 million to 726,118, is a common strategy for companies to increase their per-share price and meet minimum bid price requirements for continued listing on exchanges like Nasdaq. While reverse stock splits are often viewed negatively by the market as they signal past stock underperformance, successfully executing this consolidation removes an immediate delisting threat, providing the company with more time to improve its operational performance. Investors should monitor the company's ability to sustain its stock price above the minimum threshold and its underlying business fundamentals.
At the time of this filing, MLEC was trading at $4.34 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $45.1M. The 52-week trading range was $3.08 to $157.05. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.